When you and your prescriber are weighing Paxil vs Zoloft for anxiety, you are really comparing two of the most widely studied selective serotonin reuptake inhibitors (SSRIs). Both are FDA-approved for multiple anxiety disorders, both work for most patients, but they feel noticeably different day to day, differ in how hard they are to stop, and each treats certain conditions better than the other. This guide breaks down the pharmacology, evidence, dosing, side-effect burden, and discontinuation profile of each drug so you can have a more informed conversation with your clinician rather than a coin-flip decision.
Paroxetine (brand name Paxil) and sertraline (brand name Zoloft) both arrived in the early 1990s and became first-line anxiety treatments because they are safer in overdose than the older tricyclics and MAOIs. But “both are SSRIs” hides real clinical differences. Paxil is the most sedating and anticholinergic of the class, while Zoloft is more activating and has a cleaner drug-interaction profile. Those differences drive which patient does well on which molecule.
Quick comparison at a glance
| Feature | Paxil (paroxetine) | Zoloft (sertraline) |
|---|---|---|
| FDA-approved anxiety uses | GAD, panic disorder, social anxiety disorder, PTSD, OCD | Panic disorder, social anxiety disorder, PTSD, OCD |
| Typical anxiety dose range | 20–60 mg/day | 50–200 mg/day |
| Half-life | ~21 hours | ~26 hours (active metabolite ~66 hrs) |
| Sedation | Moderate to high | Low |
| Weight gain risk | Higher (among highest in SSRI class) | Lower to moderate |
| Sexual side effects | High | High (slightly less than Paxil in some studies) |
| GI side effects (diarrhea, nausea) | Lower | Higher |
| Anticholinergic effects | Yes (dry mouth, constipation, mild cognitive dulling) | Minimal |
| Drug interactions (CYP2D6) | Strong inhibitor, many interactions | Weak inhibitor, fewer interactions |
| Discontinuation syndrome | Severe, common | Moderate |
| Pregnancy category | Not recommended (cardiac risk) | Generally preferred SSRI in pregnancy |
How Paxil and Zoloft actually work
Both drugs block the serotonin transporter (SERT) in the synaptic cleft, raising extracellular serotonin over the following weeks. Downstream, this desensitizes 5-HT1A autoreceptors and remodels signaling in the amygdala, prefrontal cortex, and hippocampus, the circuits involved in worry, threat detection, and fear conditioning. That is why anxiolytic benefit takes 2–6 weeks, not hours.
Where they diverge:
- Paroxetine is the most potent SERT inhibitor of the SSRI class, but it also blocks muscarinic acetylcholine receptors (giving it anticholinergic side effects like dry mouth and constipation) and mildly inhibits norepinephrine reuptake at higher doses. It strongly inhibits the liver enzyme CYP2D6, which metabolizes many other drugs.
- Sertraline is a selective, cleaner SERT inhibitor with mild dopamine reuptake inhibition, which some clinicians credit for its slightly more “activating” feel. Its CYP interactions are modest, making it easier to combine with other medications.
You can read more about the underlying mechanism on the Wikipedia page for SSRIs if you want the pharmacology in more depth.
Efficacy for anxiety: what the evidence shows
Head-to-head trials and network meta-analyses generally find that Paxil and Zoloft produce comparable response and remission rates across anxiety disorders. In the large Cipriani et al. network meta-analysis of antidepressants published in The Lancet, paroxetine and sertraline both landed in the middle-to-upper tier for efficacy, with sertraline usually rating higher on the acceptability (tolerability) axis. For anxiety specifically:
Generalized anxiety disorder (GAD)
Paxil is FDA-approved for GAD; Zoloft is not, although it is widely used off-label with strong supporting trials. Effect sizes are similar. If GAD is the primary diagnosis and insurance requires an on-label agent, Paxil has the paperwork advantage.
Panic disorder
Both are FDA-approved and both work. Zoloft is often preferred as a starting agent because low doses (25 mg) can be tolerated by panic patients who are exquisitely sensitive to activation and jitteriness in the first week. Paxil is highly effective but can cause more early sedation and, later, more weight gain.
Social anxiety disorder (SAD)
Both are FDA-approved. Trials show roughly 50–60% responder rates for each. Paxil was the first SSRI approved for SAD and has the largest historical evidence base.
Post-traumatic stress disorder (PTSD)
Paroxetine and sertraline are the only two SSRIs FDA-approved for PTSD. Meta-analyses show near-equivalent effect sizes, though sertraline is often chosen first in veterans clinics because of a cleaner interaction profile with commonly co-prescribed medications.
Obsessive-compulsive disorder (OCD)
Both are approved and effective, but OCD typically requires higher doses (Paxil 40–60 mg, Zoloft 150–200 mg) and longer trials (10–12 weeks) than other anxiety indications.
The honest summary: efficacy is basically a tie. Tolerability and long-term liveability are where the choice is really made.
Side-effect profiles compared
Both drugs share the class-wide SSRI side effects: nausea, headache, insomnia or sedation, sexual dysfunction, and an initial anxiety spike in the first 1–2 weeks. But the shape of the side-effect profile differs.
Where Paxil tends to be harder
- Weight gain. Studies consistently rank paroxetine among the SSRIs most associated with clinically significant weight gain over 6–12 months.
- Sedation and cognitive dulling. The anticholinergic activity contributes to a foggy, slowed feeling in some users.
- Sexual dysfunction. Delayed orgasm, low libido, and erectile difficulty are reported at high rates.
- Constipation and dry mouth. Direct anticholinergic effects.
- Discontinuation syndrome. Because of its short half-life and no active metabolite, missing even one dose can produce dizziness, “brain zaps,” flu-like symptoms, and rebound anxiety.
Where Zoloft tends to be harder
- GI upset, especially diarrhea. Roughly 15–20% of patients report loose stools, often persistent.
- Initial activation. Jitteriness, restlessness, and insomnia are more common in the first two weeks, an issue for panic-prone patients unless the dose is started low (12.5–25 mg) and titrated slowly.
- Sweating and tremor. Somewhat more common than with Paxil.
For most patients, Zolofts side-effect burden is easier to live with long-term, which is why it is generally considered the more tolerable SSRI in the class.
Dosing and how each is started
Zoloft (sertraline): typical starting dose is 25–50 mg once daily, taken in the morning to minimize insomnia (or with the evening meal if it causes drowsiness). For panic disorder, start at 25 mg for the first week to avoid jitteriness. Increase in 25–50 mg steps every 1–2 weeks. Anxiety target range is 50–200 mg/day.
Paxil (paroxetine): typical starting dose is 10–20 mg once daily, usually in the morning. Panic disorder often starts at 10 mg. Increase in 10 mg steps no faster than weekly. Anxiety target range is 20–60 mg/day. A controlled-release form (Paxil CR) reduces peak-related nausea for some patients.
Both drugs take 2–6 weeks to produce meaningful anxiety relief, and up to 12 weeks to reach maximum benefit. That fact is worth repeating, because premature discontinuation is a leading reason SSRI trials “fail.”
Drug interactions: a decisive factor for some patients
Paroxetine is a potent CYP2D6 inhibitor, meaning it raises blood levels of drugs metabolized by that enzyme. Notable interactions include:
- Tamoxifen (paroxetine can reduce its cancer-preventive efficacy, a major reason oncologists avoid it in breast cancer patients)
- Many beta-blockers (metoprolol, carvedilol)
- Tricyclic antidepressants
- Codeine and tramadol (reduces their analgesic conversion)
- Certain antipsychotics (risperidone, aripiprazole)
Sertraline is a weak CYP2D6 inhibitor and interacts with far fewer commonly prescribed medications. For patients on multiple drugs, especially older adults, cancer patients, and cardiac patients, Zoloft is often the safer default.
Both drugs carry the class-wide warning about serotonin syndrome when combined with MAOIs, triptans, tramadol, linezolid, St. Johns Wort, or other serotonergic agents.
Discontinuation and withdrawal
This is arguably the single biggest practical difference between the two drugs.
Paroxetine has the shortest half-life of the SSRIs (~21 hours) and no active metabolite, so plasma levels drop quickly when a dose is missed. The result is a well-documented, often severe discontinuation syndrome: dizziness, electric-shock sensations (“brain zaps”), nausea, irritability, vivid dreams, and a rebound of anxiety that can be mistaken for relapse. Tapering paroxetine typically requires 4–12 weeks, sometimes longer, often using a liquid formulation to make sub-10 mg reductions.
Sertralines half-life is longer (~26 hours, with an active metabolite around 66 hours), so discontinuation symptoms are meaningfully milder. A taper over 2–6 weeks is usually adequate, though slower is always better.
If you already know you might want to stop treatment within a year or two, this alone tips many clinicians toward Zoloft.
Pregnancy and breastfeeding
Paroxetine is generally avoided in pregnancy, particularly in the first trimester, because of an increased risk of cardiac malformations (especially ventricular and atrial septal defects) reported in multiple observational studies. It carries a specific pregnancy warning.
Sertraline is one of the preferred SSRIs during pregnancy and lactation. It has the largest safety database, low placental transfer relative to other SSRIs, and minimal transfer into breast milk. It is the default choice for perinatal anxiety and depression in most guidelines.
Special populations
- Older adults: Zoloft is generally preferred. Paxils anticholinergic activity is associated with increased confusion, falls, and cognitive impairment in elderly patients. It appears on the Beers Criteria list of medications to avoid in older adults.
- Adolescents: Both carry the FDA black-box warning for increased suicidal ideation in patients under 25. Sertraline has more pediatric anxiety and OCD data.
- Patients with cardiovascular disease: Sertraline is preferred; it has the best cardiovascular safety data of any SSRI, supported by the SADHART trial in post-MI patients.
- Patients concerned about weight: Sertraline is the better first choice.
- Patients with severe insomnia at baseline: Paxils sedating profile may actually be helpful, particularly if dosed at bedtime.
How to choose between Paxil and Zoloft for anxiety
A reasonable decision framework, in consultation with your prescriber:
- Are you pregnant, planning pregnancy, or breastfeeding? Choose Zoloft.
- Are you over 65 or already on multiple medications? Lean Zoloft.
- Do you have breast cancer, are on tamoxifen, or on complex cardiac medications? Avoid Paxil.
- Is weight gain a dealbreaker? Lean Zoloft.
- Do you have severe insomnia and would benefit from a sedating agent? Paxil is reasonable.
- Have you failed Zoloft previously for GAD or SAD? Paxil is a reasonable next step.
- Do you anticipate wanting to discontinue within a year? Lean Zoloft (much easier to stop).
Both are legitimate, evidence-based choices. Neither is universally better. The best SSRI for anxiety is the one you can tolerate long enough to get better, and long enough to stay better.
Combining medication with therapy
Regardless of which SSRI you choose, the evidence is overwhelming that combined treatment, an SSRI plus cognitive behavioral therapy (CBT), outperforms either alone for most anxiety disorders, particularly panic disorder, social anxiety, and OCD. Medication reduces the physiological reactivity that makes exposure work difficult; therapy builds the skills that reduce relapse when the medication is eventually tapered.
FAQ
Is Paxil or Zoloft stronger for anxiety?
Neither is meaningfully stronger. Head-to-head trials and meta-analyses show comparable efficacy across generalized anxiety, panic, social anxiety, PTSD, and OCD. The differences are in tolerability, drug interactions, and how difficult each is to stop, not in raw anxiolytic power.
Which has fewer side effects, Paxil or Zoloft?
On average, Zoloft is easier to tolerate long-term. It causes less weight gain, less sedation, fewer anticholinergic effects, and a milder discontinuation syndrome. Its main downside is more GI upset (especially diarrhea) and early activation. Paxil is often more sedating, harder to stop, and more associated with weight gain.
Can I switch from Paxil to Zoloft (or vice versa)?
Yes, but it should be done with a prescriber. Because Paxil has a short half-life, switching from Paxil sometimes triggers discontinuation symptoms unless a cross-taper is used. Switching from Zoloft to Paxil is generally smoother. Never combine SSRIs at full doses due to serotonin syndrome risk.
How long until either drug starts working for anxiety?
Expect noticeable improvement in 2–4 weeks and full benefit at 6–12 weeks, particularly for OCD and social anxiety. Side effects usually appear first and improvement second. Knowing this in advance is often what allows patients to stay on treatment long enough to benefit.